Article Details

Characteristics of patients who developed transient anti-adalimumab antibodies

Retrieved on: 2025-09-24 18:45:32

Tags for this article:

Click the tags to see associated articles and topics

Characteristics of patients who developed transient anti-adalimumab antibodies. View article details on hiswai:

Excerpt

Adalimumab is a monoclonal antibody approved for the treatment of autoimmune diseases and non-infectious uveitis (NIU). It targets tumor necrosis ...

Article found on: joii-journal.springeropen.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo